DNLI

NASD Denali Therapeutics Inc.
Oct 7, 2026 · 6:33 AM ET LAST TRADE Market Closed

$19.28 ↑ +0.00 (+0.00%) Trading Up from the previous close of $19.28

YTD change
+16.78%
vs 20-day SMA
-6.21%
vs 200-day SMA
-8.55%

Price ranges

Previous day
$19.03 $19.97
open $19.93 close $19.28
-$0.65 (-3.26%)
Today
$0.00 $0.00
$19.28
Past week
$19.03 $21.09
from $20.81 now $19.28
-$1.53 (-7.35%)
Past month
$19.03 $22.08
from $22.08 now $19.28
-$2.80 (-12.68%)
This year
$15.34 $27.30
from $16.51 now $19.28
+$2.77 (+16.78%)

Price & Performance

-0.13 (-0.67%) / 6M

$17.38$20.90$24.42$27.94Apr 7Jul 8Oct 6

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 79.5% away from all-time highs of $93.94
  • DNLI is up 17% since the beginning of the year
  • DNLI is up 29% over the past 12 months
  • DNLI is down 13% over the past 1 month
  • 11% of all DNLI investors are betting against DNLI

DNLI reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +29.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.68
Earnings momentum -83.4% Quarterly EPS growth
Quarterly change -83.4%

Valuation

P/E ratio N/A
Enterprise value $2.9B
Beta 1.52

Balance sheet & scale

IncomeN/A
Revenue$3.6M
Cash$710.5M
Debt$37.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $3.1B

Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau. The company was founded by Ryan J. Watts, Marc Tessier-Lavigne, and Alexander Schuth on October 14, 2013 and is headquartered in San Francisco, CA.

Competitor comparison

TickerCompany PriceChange
CMXHF CSL Limited $127.68 +0.14%
ARGX argenx SE Sponsored ADR $930.52 +1.93%
ONC BeOne Medicines Ltd. Sponsored ADR $362.78 +0.31%
WXXWY WuXi Biologics (Cayman) Inc. Unsponsored ADR $14.79 +3.43%
INCY Incyte Corporation $112.73 -1.23%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.